Published in PLoS One on July 13, 2011
Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women. PLoS One (2013) 0.82
Human papillomavirus genotypes in human immunodeficiency virus-positive patients with anal pathology in Madrid, Spain. Diagn Pathol (2013) 0.79
HPV typing of high-grade dysplasia (CIN III) in cone biopsies of 38 HPV-vaccinated women. Virchows Arch (2013) 0.75
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (1985) 95.08
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer (2007) 10.29
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol (2010) 9.86
Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev (2005) 9.47
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer (2003) 8.01
Chapter 2: The burden of HPV-related cancers. Vaccine (2006) 7.70
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology (2010) 7.24
Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer (2004) 6.99
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis (2007) 6.86
Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst (1995) 6.24
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol (2002) 5.63
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis (2009) 5.09
Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer (2003) 4.40
Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer (2009) 4.28
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst (2010) 4.20
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. J Infect Dis (2009) 3.55
Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev (2005) 3.40
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer (2009) 3.15
Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer (2009) 2.90
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document. Ann Oncol (2010) 1.86
Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr (2003) 1.82
Global proficiency study of human papillomavirus genotyping. J Clin Microbiol (2010) 1.78
A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Gynecol Oncol (2008) 1.63
Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol (2009) 1.45
PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol (2004) 1.22
Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer (2008) 1.17
Human papillomavirus infections and vulvar disease development. Cancer Epidemiol Biomarkers Prev (2009) 1.15
Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol (2007) 1.12
Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol (2004) 1.10
Human papillomavirus infection and tumours of the anal canal: correlation of histology, PCR detection in paraffin sections and serology. APMIS (2007) 1.00
Evaluation of different techniques for identification of human papillomavirus types of low prevalence. J Clin Microbiol (2008) 0.99
Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination. Am J Surg Pathol (2007) 0.91
Human papilloma viruses and cancer. Bibl Haematol (1975) 0.90
Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union. J Med Virol (2007) 0.90
Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J Med Virol (1999) 0.89
Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies. Eur J Clin Microbiol Infect Dis (2006) 0.88
The frequency of human papillomavirus infection in polish patients with vulvar squamous cell carcinoma. Int J Gynecol Cancer (2010) 0.82
Genotype-specific human papillomavirus detection in cervical smears. Acta Biochim Pol (2008) 0.80
The diagnostics and prevalence of genital human papillomavirus (HPV) infection in Hungary. Eur J Obstet Gynecol Reprod Biol (2002) 0.78
Cervical cytology biobanking in Europe. Int J Biol Markers (2010) 0.78
Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia. Cancer Epidemiol (2010) 0.78
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine (2008) 4.82
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer (2009) 3.64
Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med (2015) 3.37
Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA (2009) 3.28
Fertility-sparing surgery in patients with cervical cancer. Lancet Oncol (2010) 2.17
Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types. Cancer Cytopathol (2013) 2.04
Predicting term birth weight using ultrasound and maternal characteristics. Eur J Obstet Gynecol Reprod Biol (2006) 2.02
Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol (2006) 1.77
High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer (2012) 1.71
Less radical surgery than radical hysterectomy in early stage cervical cancer: a pilot study. Gynecol Oncol (2009) 1.70
Human tumor cells killed by anthracyclines induce a tumor-specific immune response. Cancer Res (2011) 1.62
p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis. Cancer Cytopathol (2012) 1.60
Cribriform adenocarcinoma of minor salivary gland origin principally affecting the tongue: characterization of new entity. Am J Surg Pathol (2011) 1.53
Human papillomavirus seropositivity and risks of head and neck cancer. Int J Cancer (2007) 1.39
Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers. Cancer Causes Control (2010) 1.30
Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix. Int J Cancer (2013) 1.25
A less radical treatment option to the fertility-sparing radical trachelectomy in patients with stage I cervical cancer. Gynecol Oncol (2008) 1.23
The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev (2004) 1.18
Nucleic acid tests for the detection of alpha human papillomaviruses. Vaccine (2012) 1.17
HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol (2007) 1.13
Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer. Int J Cancer (2010) 1.12
Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers. Int J Cancer (2008) 1.05
Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study. Breast J (2009) 1.05
Comprehensive control of human papillomavirus infections and related diseases. Vaccine (2013) 1.02
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]. Epidemiol Prev (2012) 1.01
Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol (2013) 1.01
Evidence for vertical transmission of HPV from mothers to infants. Infect Dis Obstet Gynecol (2010) 1.00
Harmonization may be counterproductive--at least for parts of Europe where public health research operates effectively. Eur J Public Health (2011) 0.99
Evaluation of different techniques for identification of human papillomavirus types of low prevalence. J Clin Microbiol (2008) 0.99
Treatment of a large left main coronary artery thrombus by aspiration thrombectomy. J Thromb Thrombolysis (2008) 0.98
Dual hereditary jaundice: simultaneous occurrence of mutations causing Gilbert's and Dubin-Johnson syndrome. Gastroenterology (2005) 0.97
Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study. Int J Cancer (2006) 0.97
The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments. Int J Cancer (2014) 0.96
Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers? Cancer Epidemiol Biomarkers Prev (2008) 0.96
Improving the quality of communication in organised cervical cancer screening programmes. Patient Educ Couns (2008) 0.96
European Commission's proposal for a council recommendation on cancer screening. BMJ (2003) 0.96
A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening. Int J Cancer (2006) 0.95
Poorly differentiated endocrine carcinoma and intraductal papillary-mucinous neoplasm of the pancreas: Description of an unusual case. Pathol Res Pract (2007) 0.95
Prior knowledge of HPV status improves detection of CIN2+ by cytology screening. Am J Obstet Gynecol (2011) 0.95
High hydrostatic pressure induces immunogenic cell death in human tumor cells. Int J Cancer (2014) 0.94
A framework provided an outline toward the proper evaluation of potential screening strategies. J Clin Epidemiol (2013) 0.93
High burden of breast cancer in Belgium: recent trends in incidence (1999-2006) and historical trends in mortality (1954-2006). Arch Public Health (2011) 0.93
Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective study. Am J Obstet Gynecol (2008) 0.92
Current status of sentinel lymph node mapping in the management of cervical cancer. Expert Rev Anticancer Ther (2013) 0.92
Visual inspection with acetic acid as a cervical cancer test: accuracy validated using latent class analysis. BMC Med Res Methodol (2007) 0.92
Changes in type-specific human papillomavirus load predict progression to cervical cancer. J Cell Mol Med (2012) 0.92
Thirty years of research on infection and prostate cancer: no conclusive evidence for a link. A systematic review. Urol Oncol (2012) 0.91
Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination. Am J Surg Pathol (2007) 0.91
Further data on sentinel lymph node mapping in vulvar cancer by blue dye and radiocolloid Tc99. Int J Gynecol Cancer (2007) 0.90
Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping. Am J Obstet Gynecol (2009) 0.90
What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination. Eur J Cancer (2009) 0.90
Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study. BMC Cancer (2011) 0.90
The role of neoadjuvant chemotherapy and surgery in cervical cancer. Int J Gynecol Cancer (2010) 0.90
Prevalence and viral load of 51 genital human papillomavirus types and three subtypes. Int J Cancer (2012) 0.90
Head and neck cancer associated with herpes simplex virus 1 and 2 and other risk factors. Oral Oncol (2006) 0.89
A prospective study of sentinel lymph node status and parametrial involvement in patients with small tumour volume cervical cancer. Gynecol Oncol (2008) 0.88
Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology. PLoS One (2011) 0.88
Impact of implementing a nationwide cervical cancer screening program on female population coverage by Pap-tests in Estonia. Tumori (2010) 0.88
Sexually transmitted infections and prostate cancer among men in the U.S. military. Cancer Epidemiol Biomarkers Prev (2009) 0.88
Causes and relevance of unsatisfactory and satisfactory but limited smears of liquid-based compared with conventional cervical cytology. Arch Pathol Lab Med (2012) 0.87
Molecular genetic analysis of 103 sporadic colorectal tumours in Czech patients. PLoS One (2011) 0.87
HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy. PLoS One (2011) 0.87
Cytologic detection of cervical abnormalities using liquid-based compared with conventional cytology: a randomized controlled trial. Obstet Gynecol (2008) 0.87
HPV-based cervical-cancer screening in China. Lancet Oncol (2010) 0.87
Markers of HPV infection and survival in patients with head and neck tumors. Int J Cancer (2013) 0.86
Impact of genetic notification on smoking cessation: systematic review and pooled-analysis. PLoS One (2012) 0.85
Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors. J Surg Oncol (2012) 0.85
Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions. Cancer Epidemiol Biomarkers Prev (2013) 0.85
Review of neoadjuvant chemotherapy and trachelectomy: which cervical cancer patients would be suitable for neoadjuvant chemotherapy followed by fertility-sparing surgery? Curr Oncol Rep (2015) 0.85
Transmission of carcinogenic human papillomavirus types from mother to child: a meta-analysis of published studies. Eur J Cancer Prev (2013) 0.84
Barriers in cervical cancer screening programs in new European Union member states. Tumori (2010) 0.84
Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand (2010) 0.83
A prospective study in detection of lower-limb lymphedema and evaluation of quality of life after vulvar cancer surgery. Int J Gynecol Cancer (2012) 0.83
HPV persistence and its oncogenic role in prostate tumors. J Med Virol (2012) 0.83
Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. Gynecol Oncol (2009) 0.82
Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women. PLoS One (2013) 0.82
Cervical screening according to age and HPV status. BMJ (2009) 0.81
Current status of sentinel lymph node mapping in the management of endometrial cancer. Expert Rev Anticancer Ther (2013) 0.81
The use of human tissue in epidemiological research; ethical and legal considerations in two biobanks in Belgium. Med Health Care Philos (2010) 0.81
Advances in fertility-sparing surgery for cervical cancer. Expert Rev Anticancer Ther (2010) 0.81
Avoiding verification bias in screening test evaluation in resource poor settings: a case study from Zimbabwe. Clin Trials (2008) 0.80
Report on the 2007 International Workshop on Human Papillomaviruses and Consensus Recommendations for Cervical Cancer Prevention. Cent Eur J Public Health (2008) 0.80